DMTK News and Press, DermTech Inc From 03/02/23

DermTech, Inc. (DMTK) Q4 2022 Earnings Conference Call March 2, 2023 05:00 PM ET Company Participants Steve Kunszabo - Head of IR John Dobak - President and CEO Kevin Sun - CFO Conference Call Participants Thomas Flaten - Lake Street Capital Stephanie Y...

DermTech press release ( NASDAQ: DMTK ): Q4 GAAP EPS of -$0.93 beats by $0.03 . Revenue of $2.99M (-5.7% Y/Y) beats by $0.43M . Covered lives increased from 91 million to 124 million and cash runway through the third quarter of 2024 Dr. John Dobak w...

- Covered lives increased from 91 million to 124 million and cash runway through the third quarter of 2024 - Dr. John Dobak will continue to serve as CEO until a successor is appointed - Board initiates comprehensive CEO search DermTech, Inc. (NASDAQ: DMTK) (“De...

Major earning expected after the bell on Thursday include: Costco Wholesale Corporation ( COST ) Broadcom ( AVGO ) ChargePoint Holdings ( CHPT ) Marvell Technology ( MRVL ) Zscaler ( ZS ) For further details see: Notable earnings after Thursday'...

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, will host a conference call and webcast on Thursday, March 2, 2023 at 5:00 p.m. Eastern Time (ET) to discuss the Company's f...

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that U.S. General Services Administration has recommended the Company’s foundational assay included i...

Summary After an extraordinarily tough 2022, January 2023 was jubilant and a great month for bulls. The Russell 2000 was up 9.8% and I'm happy to report I posted a +21% total return, during the month of January 2023. This piece mostly discusses my numerous mistakes, notably on the p...

Summary January 2023 was an amazing month to be long equities. The Russell 2000 index was up 9.8%. Before the first opening bell of 2023, I created an equal weighted and bespoke list of twenty nine stocks for my January Effect 2023 model portfolio. The January Effect 2023 portfolio ...

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to four new employees of restricted stock units representing the contingent right to receive up to...

Molecular diagnostic company DermTech ( NASDAQ: DMTK ) added ~17% morning hours Monday after announcing favorable coverage policies from two commercial payers for its DermTech Melanoma Test (DMT). The decisions by Blues plan in Hawaii and an unnamed not-for-profit health plan in N...